Another potential deal locked down for trials and testing.
Though on a ST there is no impact to RGI, I believe RGI will sprint towards increasing sales and service revenue at the end of FY19.
Good problem to have, to see how RGI can scale up Rotogrow builds to meet forecasted significant demand globally